Intratumoral Cellular Heterogeneity: Implications for Drug Resistance in Patients with Non-Small Cell Lung Cancer

SIMPLE SUMMARY: The number of druggable tumor-specific molecular alterations in the treatment of non-small cell lung cancer (NSCLC) has grown significantly in the past decade. Emerging technologies such as liquid biopsy and single-cell methods allow for studying targetable drivers and develop person...

Descripción completa

Detalles Bibliográficos
Autores principales: Gregorc, Vanesa, Lazzari, Chiara, Mandalá, Mario, Ippati, Stefania, Bulotta, Alessandra, Cangi, Maria Giulia, Khater, Abdelrahman, Viganò, Maria Grazia, Mirabile, Aurora, Pecciarini, Lorenza, Ogliari, Francesca Rita, Arrigoni, Gianluigi, Grassini, Greta, Veronesi, Giulia, Doglioni, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122731/
https://www.ncbi.nlm.nih.gov/pubmed/33922215
http://dx.doi.org/10.3390/cancers13092023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122731/
https://www.ncbi.nlm.nih.gov/pubmed/33922215
http://dx.doi.org/10.3390/cancers13092023

Ejemplares similares